NCT03450265View on ClinicalTrials.gov

Hemopatch Compared to TachoSil in Postoperative Air Leak Duration After Pulmonary Resection

NACompletedINTERVENTIONAL
Enrollment

279

Participants

Timeline

Start Date

June 26, 2018

Primary Completion Date

July 9, 2019

Study Completion Date

July 9, 2019

Conditions
Air Leak From Lung
Interventions
DEVICE

Hemopatch

Applied according to the current instruction for use (IFU). According to the IFU, a maximum of 7 Hemopatch 45 x 90 mm patches can be used in adults.

DEVICE

Tachosil

Applied according to the current instruction for use (IFU).

Trial Locations (14)

144

Baxter Investigational Site, Rome

151

Baxter Investigational Site, Rome

168

Baxter Investigational Site, Rome

20141

Baxter Investigational Site, Milan

28006

Baxter Investigational Site, Madrid

28040

Baxter Investigational Site, Madrid

28046

Baxter Investigational Site, Madrid

28905

Baxter Investigational Site, Madrid

28933

Baxter Investigational Site, Madrid

35128

Baxter Investigational Site, Padua

41009

Baxter Investigational Site, Seville

46600

Baxter Investigational Site, Alzira

56124

Baxter Investigational Site, Pisa

95123

Baxter Investigational Site, Catania

All Listed Sponsors
lead

Baxter Healthcare Corporation

INDUSTRY

NCT03450265 - Hemopatch Compared to TachoSil in Postoperative Air Leak Duration After Pulmonary Resection | Biotech Hunter | Biotech Hunter